Archive

Category: direct-to-consumer

4 digital health trends for 2022

Funding for digital health is blowing up, and the sky’s the limit for a healthcare world suddenly, and solidly, committed to tech innovations. Here’s what we can expect to see more of next year.

23andMe to buy online pharmacy Lemonaid for $400M

The company plans to pair its direct-to-consumer genetic testing with Lemonaid’s online coaching and prescription delivery. It plans to buy the company for $400 million in stock and cash.

Sesame adds online pharmacy to cash-pay marketplace

The startup, where patients access cash-pay telehealth and in-person visits, recently added prescription delivery through Truepill. It’s offering a list of generic medications for $5.

D2C in healthcare: Why now is the perfect time

Opportunities exist in many areas of the industry, and patients are hungrier than ever for more engaging and humane experiences. For D2C brands that are ready to capitalize on the changing market, the sky’s the limit.

Sidestepping the system – Is D2C the next winning model in healthcare?

While D2C can enable creativity in customer acquisition and B2B strategies allow for rapid monetization, companies must thoughtfully target consumers, track clinical outcomes, and demonstrate cost-savings.

Strategies that will help make 2021 a banner year for life sciences industries

Covid-19 showed that pharma companies can be nimble and implement changes that prevent processes from weighing down on operations. But which of these operational and strategic changes will stand the test of time and make this year and the future bright for the industry?